Abbreviation
|
Definition
|
8-OH-dG |
8-hydroxy-2’-deoxyguanosine |
AGEs |
Advanced glycation end-products |
AlaGln |
Alanyl-glutamine |
CAPD |
Continuous ambulatory peritoneal dialysis |
CKD |
Chronic kidney disease |
CRP |
C-reactive protein |
CSR |
Cytoprotective cellular stress responses |
CV |
Cardiovascular |
ESRD |
End-stage renal disease |
GDPs |
Glucose degradation products |
HD |
Hemodialysis |
IL-6 |
Interleukin-6 |
MCP-1 |
Monocyte chemotactic peptide-1 |
MDA |
Malondialdehyde |
NAC |
N-acetylcysteine |
NADPH |
Nicotinamide adenine dinucleotide phosphate |
NF-kB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
NOS |
Nitric oxide synthase |
OS |
Oxidative stress |
PD |
Peritoneal dialysis |
PM |
Peritoneal membrane |
PMC |
Peritoneal mesothelial cell |
RAGE |
Receptor for AGEs |
ROS |
Reactive oxygen species |
RRF |
Residual renal function |
RRT |
Renal replacement therapy |
TBARS |
Thiobarbituric acid reactive substances |
TGF-β |
Tumor growth factor-β |
TNF-α |
Tumor necrosis factor-α |
VEGF |
Vascular endothelial growth factor |